Clearmind Medicine Inc. Archives

Green Market Report

Home
News Briefs
Spotlight
Videos
Events
- Crain’s Cleveland Business Cannabis Summit
- Upcoming Events
Awards
- 2023 Notable Leaders in Cannabis

John SchroyerDecember 6, 2023

The push toward mainstream legitimacy is largely what's fueled the rise in dealmaking.

Debra BorchardtSeptember 19, 2023

Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), closed its United States-only public offering raising approximately $2.25 million. The offering consisted of 7,500,000 common shares and pre-funded warrants and 7,500,000 common warrants. Clearmind said it plans to use the money for general corporate purposes, which may include operating expenses, research, and development, including clinical and pre-clinical […]

About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis

Recent Tweets

Company

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

In other news

The Daily Hit: January 4, 2024

Connecticut Attorney General Tells Unlicensed Cannabis Events Company to Stop

Testing Concerns Lead to Quarantine for 70% of Mississippi MMJ Goods

Tag: Clearmind Medicine Inc.

Psychedelic Deals, Partnerships Skyrocket 500% Since 2019

Clearmind Medicine Raises $2.25 Million

The Daily Hit - TEST TEST TEST

Lykos Therapeutics Secures $100M in Series A Funding, Rebrands from MAPS PBC

Functional Mushrooms Move Into Mainstream as Wellness Trend Grows

Get the latest cannabis news delivered right to your inbox

Get the latest cannabis news delivered right to your inbox